Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial)
Cancers · 14.12.2024 · 16 (24) · 4173
DOI: 10.3390/cancers16244173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 14.12.2024. Verfasst von Tatiana Mögele und 14 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Förderkreis des Tumorzentrums Augsburg e.V..
Abstract (Originalsprache)
Background/Objectives: Locally advanced rectal cancer is treated with neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME). As this approach achieves complete pathologic remissions (pCR) in approximately 30% of patients, it raises the question of whether surgery is always necessary. Non-surgical strategies, such as “watch and wait” (W&W), have shown similarly promising outcomes. However, there is an unmet need for reliable biomarkers predicting pCR. Analysis of circulating tumor DNA (ctDNA) has shown potential for monitoring treatment response and detecting minimal residual disease. We hypothesized that monitoring ctDNA changes during nCRT might facilitate the identification of individuals who achieve pCR.
Methods
In the prospective single-center NEORECT trial, the plasma of forty rectal cancer patients was collected before, during, and after nCRT and before TME. Informative somatic mutations were identified in tissue biopsies by NGS and subsequently used for ctDNA quantification by dPCR.
Results
The results identified three distinct ctDNA patterns: increase, decrease, and absence. Remarkably, undetectable DNA was observed in good responders, while a tenfold ctDNA increase was associated with the emergence of new metastases. Despite these insights, ctDNA alone demonstrated low specificity, with no significant correlation to pCR or long-term prognosis. A multimodal approach incorporating routinely available clinical parameters remains inadequate for accurately predicting pCR prior to TME.
Conclusions
In conclusion, the NEORECT trial establishes the feasibility of ctDNA-based personalized monitoring for rectal cancer patients undergoing nCRT. However, the utility of ctDNA in enhancing pCR prediction for a W&W strategy warrants further investigation. Larger studies integrating multi-gene analyses and expanded clinical datasets are essential in the future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pathology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.
- Bavarian Cancer Research Center (BZKF), Germany.
- Radiotherapy, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.
- General and Visceral Surgery, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.
- Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.
- Hematology and Oncology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.
ORCID-Profile: Florian Sommer, Maximilian Schmutz, Thomas Kröncke, Sebastian Dintner, Rainer Claus
Förderung
- Förderkreis des Tumorzentrums Augsburg e.V.
Zitieren
APA
Mögele, T., Höck, M., Sommer, F., Friedrich, L., Sommer, S., Schmutz, M., Altenburger, A., Messmann, H., Anthuber, M., Kröncke, T., Stüben, G., Trepel, M., Märkl, B., Dintner, S., & Claus, R. (2024). Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial). Cancers, 16(24), 4173. https://doi.org/10.3390/cancers16244173
Vancouver
Mögele T, Höck M, Sommer F, Friedrich L, Sommer S, Schmutz M, et al. Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial). Cancers. 2024;16(24):4173. doi:10.3390/cancers16244173
BibTeX
@article{Mgele2024,
author = {Mögele, Tatiana and Höck, Michael and Sommer, Florian and Friedrich, Lena and Sommer, Sebastian and Schmutz, Maximilian and Altenburger, Amadeus and Messmann, Helmut and Anthuber, Matthias and Kröncke, Thomas and Stüben, Georg and Trepel, Martin and Märkl, Bruno and Dintner, Sebastian and Claus, Rainer},
title = {Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial)},
journal = {Cancers},
year = {2024},
volume = {16},
number = {24},
pages = {4173},
doi = {10.3390/cancers16244173}
}
EUVIMED